CorMedix CRMD
NASDAQ CRMD
$7.42 -0.28 (-3.64%)
At close: Oct 1, 2026 · 4:00 PM EDT

CorMedix (CRMD) Liabilities and Shareholders Equity (2010 - 2026)

Updated

CorMedix (CRMD) posted Liabilities and Shareholders Equity of $904.05 million for Q2 2026, up 257.9% from $252.6 million a year earlier.

Analysis

CorMedix (CRMD) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, CorMedix's Liabilities and Shareholders Equity came in at $826.14 million, up 595.1% from FY2024.

  • Annual Liabilities and Shareholders Equity has increased for three consecutive years, with a five-year compound annual growth rate of 75.7% (FY2020 to FY2025).
  • In prior years, CorMedix's Liabilities and Shareholders Equity was $118.85 million in FY2024 (+44.8%), $82.06 million in FY2023 (+32.3%), $62.04 million in FY2022 (-10.0%) and $68.95 million in FY2021 (+39.8%).
  • The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2010.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in six of the last seven quarters, with growth averaging 315.4%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2025, with growth of 867.8%; the weakest was Q1 2022, with a decline of 22.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 CorMedix 598.04 Mn -54.48 Mn 77.13 Mn 904.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 904.05 Mn
Dec 31, 2025 826.14 Mn
Sep 30, 2025 750.86 Mn
Jun 30, 2025 252.60 Mn
Mar 31, 2025 149.58 Mn
Dec 31, 2024 118.85 Mn
Sep 30, 2024 77.59 Mn
Jun 30, 2024 57.73 Mn
Mar 31, 2024 68.02 Mn
Dec 31, 2023 82.06 Mn
Sep 30, 2023 91.43 Mn
Jun 30, 2023 57.03 Mn
Mar 31, 2023 59.23 Mn
Dec 31, 2022 62.04 Mn
Sep 30, 2022 62.08 Mn
Jun 30, 2022 67.75 Mn
Mar 31, 2022 64.93 Mn
Dec 31, 2021 68.95 Mn
Sep 30, 2021 75.39 Mn
Jun 30, 2021 80.86 Mn
API Access

CorMedix Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CRMD&period=max&api_key=YOUR_API_KEY